0001209191-18-052826.txt : 20181001
0001209191-18-052826.hdr.sgml : 20181001
20181001170837
ACCESSION NUMBER: 0001209191-18-052826
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181001
FILED AS OF DATE: 20181001
DATE AS OF CHANGE: 20181001
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALBINI EDWARD C
CENTRAL INDEX KEY: 0001240014
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38662
FILM NUMBER: 181098347
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUTRO BIOPHARMA INC
CENTRAL INDEX KEY: 0001382101
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 452441988
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 310 UTAH AVE., SUITE 150
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-392-8412
MAIL ADDRESS:
STREET 1: 310 UTAH AVE., SUITE 150
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-10-01
0
0001382101
SUTRO BIOPHARMA INC
STRO
0001240014
ALBINI EDWARD C
C/O SUTRO BIOPHARMA, INC.
310 UTAH AVENUE, SUITE 150
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
CFO and Secretary
Common Stock
2018-10-01
4
C
0
1688
A
1688
D
Series D Preferred Stock
2018-10-01
4
C
0
41694
0.00
D
Common Stock
1688
0
D
Each share of the issuer's Series D Preferred Stock automatically converted into 0.0405 share of the issuer's Common Stock on October 1, 2018 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering pursuant to a registration statement on Form S-1 (File No. 333-227103) under the Securities Act of 1933, as amended, and had no expiration date.
/s/ Edward C. Albini
2018-10-01